Drug Research
Ausgabe 02 · Februar 2024
Zeitschrift empfehlen
eFirst
Ausgabe
Erratum
e1
Poustforoosh, Alireza; Faramarz, Sanaz; Nematollahi, Mohammad Hadi; Mahmoodi, Mehdi; Azadpour, Mahdiyeh:
Correction: Structure-Based Drug Design for Targeting IRE1: An
in Silico
Approach for Treatment of Cancer
Volltext
HTML
PDF (110 kb)
Original Article
47
Figueroa-Valverde, Lauro; Rosas-Nexticapa, Marcela; Alvarez-Ramirez, Magdalena; Melgarejo-Gutiérrez, Montserrat; Mateu-Armand, Virginia; Garcimarrero-Espino, Alejandra:
Biological Activity of a Coumarin Derivative on Heart Failure Using an Ischemia/Reperfusion Injury Model
Volltext
HTML
PDF (444 kb)
Zusatzmaterial
Additional material
53
Naderifar, Negin; Roohi, Elnaz; Sharifi, Ali; Jaafari, Nemat; Hashemian, Farshad:
Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study
Volltext
HTML
PDF (289 kb)
60
Chinraj, Vasanthi; Reddy, Ramakkamma Aishwarya; Selvaraj, Jubie; Sureshkumar, Raman:
Design, Synthesis and
In Vitro
Evaluation of Levodopa Stearic Acid Hydrazide Conjugate for the Management of Parkinson’s DiseaseNovel Conjugate for Parkinson’s Disease
Volltext
HTML
PDF (520 kb)
67
Subramanian, Gomathy; Prasad, Kaveri; Chand, Jagdish; Amarjith, Thiyyar K.; Shanish, Antony A.:
In-silico
, Synthesis, Characterization, and
In-vitro
Studies on Benzylidene-based 2-chloroquinolin Derivatives as Free Radical Scavengers in Parkinson’s Disease
Volltext
HTML
PDF (593 kb)
Zusatzmaterial
Supplementary Material
77
Kusunoki, Masataka; Hisano, Fumiya; Matsuda, Shin-ichi; Kusunoki, Akiko; Abe, Tomokazu; Tsutsumi, Kazuhiko; Miyata, Tetsuro:
Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products
Volltext
HTML
PDF (166 kb)
81
Poustforoosh, Alireza; Faramarz, Sanaz; Nematollahi, Mohammad Hadi; Mahmoodi, Mehdi; Azadpour, Mahdiyeh:
Structure-Based Drug Design for Targeting IRE1: An
in Silico
Approach for Treatment of Cancer
Volltext
HTML
PDF (580 kb)
Meistgelesen
Archiv
Kostenlose Probeausgabe
Zeitschrift
Über diese Zeitschrift
Impressum
Herausgeber
Autor*innen
Manuskript einreichen
Autorenhinweise
Abonnement
Lizenzen: Kontaktpartner Institutionen
Ihr Abonnement: Kontakt & Information
Collections
Manuskript einreichen
Autorenhinweise
Social Media
Manuskript einreichen
Autorenhinweise
Zeitschriften
Buchreihen
Login
Hilfe
Portal
Zur klassischen Webseite wechseln